Authors: PARNIS FX OLVER IN SANDEMAN T BISHOP JF LAIDLAW C

Citation: Fx. Parnis et al., A PHASE-II TRIAL OF CISPLATIN AND INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BLADDER-CANCER, American journal of clinical oncology, 20(3), 1997, pp. 319-321

Authors: PARNIS FX COLEMAN RE HARPER PG PICKERING D TOPHAM C WHITTINGTON JR TEDESCHI M

Citation: Fx. Parnis et al., A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CLINICAL-TRIAL ASSESSINGTHE TOLERABILITY AND EFFICACY OF GLUTATHIONE AS AN ADJUVANT TO ESCALATING DOSES OF CISPLATIN IN THE TREATMENT OF ADVANCED OVARIAN-CANCER, European journal of cancer, 31A(10), 1995, pp. 1721-1721

Authors: OBRIEN PC PARNIS FX

Citation: Pc. Obrien et Fx. Parnis, SALVAGE RADIOTHERAPY FOLLOWING CHEMOTHERAPY FAILURE IN HODGKINS-DISEASE - WHAT IS ITS ROLE, Acta oncologica, 34(1), 1995, pp. 99-104

Authors: HIGHLEY MS PARNIS FX TROTTER GA HOUSTON SJ PENSON RT HARPER PG MASON RC

Citation: Ms. Highley et al., COMBINATION CHEMOTHERAPY WITH EPIRUBICIN, CISPLATIN AND 5-FLUOROURACIL FOR THE PALLIATION OF ADVANCED GASTRIC AND ESOPHAGEAL ADENOCARCINOMA, British Journal of Surgery, 81(12), 1994, pp. 1763-1765